Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1o5g | CR9 | Prothrombin | 3.4.21.5 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
1o5g | CR9 | Prothrombin | 3.4.21.5 | 1.000 | |
1gj5 | 130 | Prothrombin | 3.4.21.5 | 0.715 | |
1o2g | 696 | Prothrombin | 3.4.21.5 | 0.680 | |
1gj4 | 132 | Prothrombin | 3.4.21.5 | 0.592 | |
4e7r | 0NW | Prothrombin | 3.4.21.5 | 0.570 | |
4hfp | 15U | Prothrombin | 3.4.21.5 | 0.547 | |
2cf9 | 348 | Prothrombin | 3.4.21.5 | 0.546 | |
2cn0 | F25 | Prothrombin | 3.4.21.5 | 0.522 | |
1ypg | UIR | Prothrombin | 3.4.21.5 | 0.521 | |
2bvs | 2CE | Prothrombin | 3.4.21.5 | 0.516 | |
1d3p | BT3 | Prothrombin | 3.4.21.5 | 0.514 | |
1xm1 | GAH | Prothrombin | 3.4.21.5 | 0.511 | |
4ayv | 9MQ | Prothrombin | 3.4.21.5 | 0.509 | |
1oyt | FSN | Prothrombin | 3.4.21.5 | 0.506 | |
2v3o | I26 | Prothrombin | 3.4.21.5 | 0.506 | |
3hat | GLY_VAL_ARG_RNG | Prothrombin | 3.4.21.5 | 0.506 | |
1ypj | UIB | Prothrombin | 3.4.21.5 | 0.503 | |
1zsk | 421 | Coagulation factor XI | 3.4.21.27 | 0.501 | |
4loy | 6XS | Prothrombin | 3.4.21.5 | 0.501 | |
4lxb | 7R9 | Prothrombin | 3.4.21.5 | 0.499 | |
1mu8 | CDB | Prothrombin | 3.4.21.5 | 0.497 | |
2gde | SN3 | Prothrombin | 3.4.21.5 | 0.497 | |
4ayy | 9MX | Prothrombin | 3.4.21.5 | 0.493 | |
1c4v | IH2 | Prothrombin | 3.4.21.5 | 0.491 | |
4fue | 7UP | Urokinase-type plasminogen activator | 3.4.21.73 | 0.491 | |
2a2x | NA9 | Prothrombin | 3.4.21.5 | 0.490 | |
2viv | VG2 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.489 | |
1ype | UIP | Prothrombin | 3.4.21.5 | 0.482 | |
2jh6 | 894 | Prothrombin | 3.4.21.5 | 0.482 | |
2jh0 | 701 | Prothrombin | 3.4.21.5 | 0.477 | |
1uvs | I11 | Prothrombin | 3.4.21.5 | 0.476 | |
2ifa | FMN | Uncharacterized protein | / | 0.473 | |
4xgu | ADP | Putative pachytene checkpoint protein 2 | / | 0.470 | |
2zhf | 49U | Prothrombin | 3.4.21.5 | 0.467 | |
1ghv | 120 | Prothrombin | 3.4.21.5 | 0.464 | |
3ig6 | 438 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.463 | |
3wag | TYD | Glycosyltransferase | / | 0.460 | |
4j7g | TRH | PCZA361.3 | / | 0.460 | |
2il2 | LIX | Renin | 3.4.23.15 | 0.459 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.459 | |
1riw | OSC | Prothrombin | 3.4.21.5 | 0.458 | |
2ivn | ANP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.458 | |
1bim | 0QB | Renin | 3.4.23.15 | 0.457 | |
2psw | COA | N-alpha-acetyltransferase 50 | / | 0.457 | |
3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.457 | |
2ziq | 26U | Prothrombin | 3.4.21.5 | 0.456 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.455 | |
4j7h | TRH | PCZA361.3 | / | 0.455 | |
3k5c | 0BI | Beta-secretase 1 | 3.4.23.46 | 0.454 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.454 | |
4uug | PXG | Branched-chain amino acid aminotransferase, putative | / | 0.454 | |
1d9i | 00P | Prothrombin | 3.4.21.5 | 0.453 | |
2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.453 | |
4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.453 | |
2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.452 | |
2yy2 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
4jsr | 1NQ | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 3.5.1 | 0.452 | |
5dp2 | NAP | CurF | / | 0.451 | |
1kbo | 340 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.450 | |
3vyd | VYD | Renin | 3.4.23.15 | 0.449 | |
1ex7 | 5GP | Guanylate kinase | 2.7.4.8 | 0.448 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
2qim | ZEA | Class 10 plant pathogenesis-related protein | / | 0.448 | |
2xlu | NA7 | Putative flavin-containing monooxygenase | / | 0.448 | |
3d91 | REM | Renin | 3.4.23.15 | 0.448 | |
3oqf | S51 | Renin | 3.4.23.15 | 0.448 | |
4ozt | P1A | Ecdysone receptor, putative | / | 0.448 | |
1w7g | MIU | Prothrombin | 3.4.21.5 | 0.447 | |
3vsx | R32 | Renin | 3.4.23.15 | 0.447 | |
4g2j | 0WF | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.447 | |
2hiz | LIJ | Beta-secretase 1 | 3.4.23.46 | 0.446 | |
3vsw | R31 | Renin | 3.4.23.15 | 0.446 | |
3hl0 | NAD | Maleylacetate reductase | / | 0.445 | |
4dri | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.445 | |
4dri | RAP | Peptidyl-prolyl cis-trans isomerase FKBP5 | 5.2.1.8 | 0.445 | |
3egk | M18 | Prothrombin | 3.4.21.5 | 0.444 | |
3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.444 | |
4g1c | CNA | NAD-dependent protein deacylase sirtuin-5, mitochondrial | / | 0.444 | |
1ps9 | MDE | 2,4-dienoyl-CoA reductase | 1.3.1.34 | 0.443 | |
3up5 | FAD | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.443 | |
4a84 | DXC | Major pollen allergen Bet v 1-A | / | 0.443 | |
2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
3dyl | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
5f8e | SAH | Possible transcriptional regulatory protein | / | 0.442 | |
1icq | OPD | 12-oxophytodienoate reductase 1 | 1.3.1.42 | 0.440 | |
1vce | SAH | Diphthine synthase | / | 0.440 | |
3dop | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.440 | |
3e34 | ED1 | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | / | 0.440 | |
3e34 | ED1 | Protein farnesyltransferase subunit beta | 2.5.1.58 | 0.440 | |
4kby | C2E | Stimulator of interferon genes protein | / | 0.440 |